Status epilepticus attributed to moxifloxacin in an adolescent patient with spina bifida occulta.
Qiao
Liang
L
Cui
Xin
X
Li
Yongjie
Y
D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001372:Aza Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D024841:Fluoroquinolones; D006801:Humans; D000077266:Moxifloxacin; D011804:Quinolines / Q000009:adverse effects* / Q000627:therapeutic use; D051437:Renal Insufficiency; D016136:Spina Bifida Occulta; D013226:Status Epilepticus / Q000139:chemically induced* / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy*; D055815:Young Adult
D000890:Anti-Infective Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin
Ann Pharmacother. 2001 Oct;35(10):1194-8
11675843
J Intern Med. 1990 Aug;228(2):83-90
2394974
Psychiatr Neurol Med Psychol (Leipz). 1990 Oct;42(10):605-8
2127641
Ann Pharmacother. 2004 Feb;38(2):235-7
14742757
Pediatr Neurol. 1995 Jul;13(1):29-32
7575845
Neurosurg Clin N Am. 1995 Apr;6(2):269-77
7620353
Clin Pharmacol Ther. 1981 Aug;30(2):239-45
7249508